Pathological systematic review on novel biomarkers for diagnosis of liver cancer
By: Jadhav, Kaushal P
.
Contributor(s): Borole, Vilas C.
Publisher: Jalgaon Association of Pharmaceutical Teachers of India (APTI) 2021Edition: Vol.22(1), Apr-Aug.Description: 11-26p.Subject(s): PHARMACEUTICSOnline resources: Click here
In:
Advances in pharmacology and toxicologySummary: Liver cancer or hepatocellular carcinoma (HCC) is the fifth most frequent neoplasm and the third most common cause of maliganant tumors leading to cancer-related death in the world. Patients with HCC have poor survival rate. Oncology or cancer biology based on technical advances help in identification of pathological, genetic, and molecular events occurring dureing hepatocarcinogenesis leading to discovery of numerous potential biomarkers in theis disease ......
| Item type | Current location | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|---|
Articles Abstract Database
|
School of Pharmacy Archieval Section | Not for loan | 2022-1039 |
Total holds: 0
Liver cancer or hepatocellular carcinoma (HCC) is the fifth most frequent neoplasm and the third most common cause of maliganant tumors leading to cancer-related death in the world. Patients with HCC have poor survival rate. Oncology or cancer biology based on technical advances help in identification of pathological, genetic, and molecular events occurring dureing hepatocarcinogenesis leading to discovery of numerous potential biomarkers in theis disease ......
Click on an image to view it in the image viewer
There are no comments for this item.